Multiple Myeloma Specialist

Hear directly from experts who specialize in multiple myeloma.

Multiple myeloma is a cancer that starts in a type of white blood cell called plasma cells. While it is not curable, it is very treatable with a lot of research and clinical trials focused on trying to extend life on the path to a cure.



Explore interviews with medical experts who specialize in multiple myeloma, including oncologists who talk about latest in treatment trends amid a rapidly-shifting landscape that seems to favor new combinations. Also learn more about CAR T cell therapy and bispecifics in multiple myeloma.

Oncologists

Research on Black Myeloma Patients, Access & Disparities



Patient advocate Valarie Traynham and Dr. Shakira Grant discuss the barriers many Black patients face, how it impacts their care, and what can be done to help improve their outcomes.

Dr. Brandon Blue



Dr. Brandon Blue shares key strategies for better health care and saving lives, especially in communities impacted by multiple myeloma.

Irene Ghobrial, MD



Role: Clinical investigator and professor of hematological oncology
Focus: Multiple myeloma, Waldenström’s Macroglobulinemia, early screening, clinical trials
Provider:Dana-Farber Cancer Institute (Boston)

James Berenson, MD



Oncologist: Specializing in myeloma and other blood and bone disorders
Experience: 35+ years
Institution: Berenson Cancer Center

Joseph Mikhael, MD



Role: Dir. Myeloma Research, CMO at International Myeloma Foundation (IMF)
Focus: Multiple myeloma
Provider: TGen/City of Hope